We are live on ! Find out more
EAM

Exome Asset Management Portfolio holdings

AUM $193M
1-Year Est. Return 208.51%
This Fund
S&P 500
This Quarter Est. Return
+14.64%
1 Year Est. Return
+208.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$193M
AUM Growth
-$15.8M
Cap. Flow
-$20.2M
Cap. Flow %
-10.45%
Top 10 Hldgs %
42.42%
Holding
83
New
23
Increased
5
Reduced
24
Closed
27

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$4.1M
2
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$3.95M
3
MAZE
Maze Therapeutics
MAZE
+$3.91M
4
BSX icon
Boston Scientific
BSX
+$3.87M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$3.57M

Top Sells

Rank Stock Value
1
WVE icon
Wave Life Sciences
WVE
+$5.49M
2
AZN icon
AstraZeneca
AZN
+$5.26M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$4.5M
4
IMVT icon
Immunovant
IMVT
+$4.03M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$3.91M

Sector Composition

Rank Sector Weight
1 Healthcare 87.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPT
76
DELISTED
RAPT Therapeutics
RAPT
– –
-14,194
Closed -$481K
SLNO
77
PUT
DELISTED
Soleno Therapeutics
SLNO
– –
-7,100
Closed -$328K
THC icon
78
Tenet Healthcare
THC
$16.7B
– –
-6,084
Closed -$1.21M
TVTX icon
79
Travere Therapeutics
TVTX
$5.16B
– –
-89,052
Closed -$2.66M
UHS icon
80
Universal Health Services
UHS
$9.12B
– –
-17,628
Closed -$3.84M
WVE icon
81
Wave Life Sciences
WVE
$1.1B
– –
-421,488
Closed -$5.49M
WAY
82
Waystar Holding Corp
WAY
$4.24B
– –
-68,969
Closed -$2.26M
UPB
83
Upstream Bio Inc
UPB
$380M
– –
-64,845
Closed -$1.76M
1 2 3
4

Similar funds

WWC
Waypoint Wealth Counsel Atlanta, Georgia $193M AUM 30.17% 1-Year Est. Return
JHA
Jackson Hill Advisors Houston, Texas $193M AUM 4.94% 1-Year Est. Return
TDWM
Topel & Distasi Wealth Management Berkeley, California $193M AUM 12.07% 1-Year Est. Return
MUAMU
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $193M AUM 37.43% 1-Year Est. Return
DF
Downshift Financial Boulder, Colorado $193M AUM
BW
BostonPremier Wealth Hanover, Massachusetts $194M AUM 20.19% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
CWRP
Cassady Wealth & Retirement Planning Henderson, Nevada $193M AUM

Exome Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Exome Asset Management held 83 positions worth $193M, down 7.6% from $209M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Exome Asset Management withdrew a net $20.2M in Q1 2026, closing 27 positions and reducing 24 holdings. Its most notable exit was Wave Life Sciences, an estimated $5.49M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 97% a quarter earlier.

Against the trend, Exome Asset Management opened a new position in Insmed worth $4.36M.

  • Exome Asset Management's largest Q1 2026 buy was Insmed: 26,651 shares worth $4.36M.
  • Exome Asset Management added most to UnitedHealth in Q1 2026, an estimated $2.09M increase.
  • Exome Asset Management's biggest Q1 2026 reduction was Praxis Precision Medicines, cutting an estimated $3.91M.
  • Exome Asset Management fully exited Wave Life Sciences in Q1 2026, selling an estimated $5.49M.
  • Exome Asset Management's ten largest holdings make up 42% of its $193M portfolio in Q1 2026.
  • Exome Asset Management opened 23 new positions and closed 27 in Q1 2026.
  • Exome Asset Management's portfolio value fell 7.6% quarter-over-quarter to $193M.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.